MRNX 股價展望與 ETF 分析 - 配息·管理費·持股·NAV·RSI·MACD

MRNX

Defiance Daily Target 2X Long MRNA ETF

收盤價 10月27日 12:46 PM ET（韓國 10/28 01:46）

$132.11

-1.50 ▼ -1.12%

上升通道阻力線 215.81 支撐線 31.13 維持由 AI 繪製的參考線，可能有誤，僅供參考，並非預測。

詳細指標表

Category ⓘ	Equity - Leveraged / Inverse	Expense ⓘ	1.34%	Return% 1Y ⓘ	-	Total Holdings ⓘ	9	Perf Week ⓘ	-27.52%	Volume ⓘ	198,422
Asset Type ⓘ	Equities (Stocks)	AUM ⓘ	$36M	Return% 3Y ⓘ	-	NAV ⓘ	$134.36	Perf Month ⓘ	-12.3%	Avg Volume ⓘ	0.34M
ETF Type ⓘ	US Equities	Dividend TTM ⓘ	-	Return% 5Y ⓘ	-	52W High ⓘ	-42.03%	Perf Quarter ⓘ	421.04%	Rel Volume ⓘ	0.58
Active/Passive ⓘ	Active	Div Gr. 3/5Y ⓘ	-	Return% 10Y ⓘ	-	52W Low ⓘ	783.68%	Perf Half Y ⓘ	464.1%	Prev Close ⓘ	$133.61
IPO ⓘ	2026/2/4	Flows% 1M ⓘ	47.88%	Return% SI ⓘ	1287.32%	RSI (14) ⓘ	46.14	Perf YTD ⓘ	541%	Price ⓘ	$132.11
Beta ⓘ	-	Flows% 3M ⓘ	129.77%	Flows% YTD ⓘ	144.08%	Flows% 1Y ⓘ	144.08%	Perf Year ⓘ	-	Volatility(W/M) ⓘ	38.99% 22.71%
SMA20 ⓘ	-17.85%	SMA50 ⓘ	9.88%	SMA200 ⓘ	148.89%	ATR ⓘ	31.48

ETF 簡介

Defiance Daily Target 2X Long MRNA ETFMRNX | NYSE | 槓桿型查看深度分析

Defiance Daily Target 2X Long MRNA ETF is an actively managed, single-stock leveraged exchange-traded fund designed to provide 200% of the daily share price performance of Moderna, Inc. (MRNA). The fund is intended for sophisticated investors and active traders who seek to express tactical bullish views on mRNA-based biotechnology innovation through amplified daily exposure.

注意

依指數單日漲跌的 2 倍波動

長期持有會不斷損耗價值。它是為一兩天的短線交易設計的商品。

MRNX ETF 一覽

1.34% 越低越好

$36M 管理資產

9檔

掛牌日 2026年

管理方式主動管理

發行公司 Defiance

主要持有標的持有 9 檔

前 3 大持股占 基金的 29%